A Competitive Panning Method Reveals an Anti-SARS-CoV-2 Nanobody Specific for an RBD-ACE2 Binding Site

Most neutralizing antibodies neutralize the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by directly blocking the interactions between the spike glycoprotein receptor-binding domain (RBD) and its receptor, human angiotensin-converting enzyme 2 (ACE2). Here, we report a novel nanobody...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Siqi, Wang, Jiali, Chen, Hanyi, Qian, Zhaohui, Hu, Keping, Shi, Bingjie, Wang, Jianxun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964001/
https://www.ncbi.nlm.nih.gov/pubmed/36851249
http://dx.doi.org/10.3390/vaccines11020371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964001/
https://www.ncbi.nlm.nih.gov/pubmed/36851249
http://dx.doi.org/10.3390/vaccines11020371

Ejemplares similares